Stockscreener 앱 받기
3.95
1.28%
0.05
시간 외 거래:
3.99
0.04
+1.01%
전일 마감가:
$3.90
열려 있는:
$3.85
하루 거래량:
246.95K
Relative Volume:
0.71
시가총액:
$213.12M
수익:
$2.76M
순이익/손실:
$-49.12M
주가수익비율:
-2.6333
EPS:
-1.5
순현금흐름:
$-46.21M
1주 성능:
+0.00%
1개월 성능:
+45.76%
6개월 성능:
+44.16%
1년 성능:
-25.33%
1일 변동 폭
$3.77
$3.99
1주일 범위
$3.54
$4.01
52주 변동 폭
$2.20
$6.50
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
명칭
Orchestra Biomed Holdings Inc
전화
646-343-9298
주소
150 UNION SQUARE DRIVE, NEW HOPE
OBIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
3.95 | 210.42M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-20 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-03-20 | 개시 | BTIG Research | Buy |
| 2025-01-02 | 개시 | Barclays | Overweight |
| 2024-08-22 | 개시 | H.C. Wainwright | Buy |
| 2024-07-25 | 개시 | B. Riley Securities | Buy |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2023-02-24 | 개시 | Piper Sandler | Overweight |
| 2023-02-07 | 개시 | Chardan Capital Markets | Buy |
모두보기
Orchestra Biomed Holdings Inc 주식(OBIO)의 최신 뉴스
Is Orchestra BioMed Holdings Inc. reversing from oversold territoryVolume Spike & AI Driven Stock Reports - newser.com
Can Orchestra BioMed Holdings Inc. stock withstand economic slowdown2025 Market Sentiment & Breakout Confirmation Alerts - newser.com
How sentiment analysis helps forecast Orchestra BioMed Holdings Inc.July 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
Orchestra BioMed (Nasdaq: OBIO) Nov. 12 call on Medtronic collaboration, pivotal trials - Stock Titan
How to use a screener to detect Orchestra BioMed Holdings Inc. breakouts2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Is Orchestra BioMed Holdings Inc. stock supported by strong cash flowsPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Is this a good reentry point in Orchestra BioMed Holdings Inc.Earnings Risk Report & Advanced Technical Signal Analysis - newser.com
Can Orchestra BioMed Holdings Inc. stock reach $100 price targetWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Will Orchestra BioMed Holdings Inc. stock outperform tech sector in 2025Portfolio Return Report & Fast Gain Swing Trade Alerts - newser.com
Will Orchestra BioMed Holdings Inc. stock recover after recent drop2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
What to expect from Orchestra BioMed Holdings Inc. in the next 30 daysInsider Buying & Weekly Market Pulse Alerts - newser.com
The past five years for Orchestra BioMed Holdings (NASDAQ:OBIO) investors has not been profitable - Yahoo Finance
Q3 Earnings Forecast for Orchestra BioMed Issued By B. Riley - MarketBeat
Will Orchestra BioMed Holdings Inc. stock beat EPS estimatesChart Signals & Safe Entry Momentum Tips - newser.com
Exit strategy if you’re trapped in Orchestra BioMed Holdings Inc.Gap Down & Weekly Watchlist for Hot Stocks - newser.com
Custom watchlist performance reports with Orchestra BioMed Holdings Inc.2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
How currency fluctuations impact Orchestra BioMed Holdings Inc. stock2025 Investor Takeaways & Weekly Top Gainers Alerts - newser.com
Certain Stock Options of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Certain Pre-Funded Warrants of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Certain Common Stock of Orchestra BioMed Holdings, Inc. are subject to a Lock-Up Agreement Ending on 31-OCT-2025. - MarketScreener
Orchestra BioMed Holdings, Inc. Announces Strategic Developments and Financial Milestones - TradingView
What drives Orchestra BioMed Holdings Inc stock priceMarket Depth Overview & Small Capital Portfolio Tips - earlytimes.in
Orchestra BioMed Announces First Patients Enrolled in Virtue SAB US Pivotal IDE Coronary Trial - HMP Global Learning Network
Orchestra Biomed Holdings Inc (OBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.35%
자본화:
|
볼륨(24시간):